JPRN-UMIN000006659招募中未知
Examination of efficacy and safety of PEG-IFN alpha-2a plus Adefovir dipivoxil for the treatment of chronic hepatitis B - PEG-IFN alpha-2a plus Adefovir therapy for chronic hepatitis B
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2012年1月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient who is administering the sho-sai-ko-to 2. A patient with the previous history of interstitial pneumonia 3. Other chronic liver disease patients such as autoimmune hepatitis or alcoholic hepatitis 4. Patient who has previous history of hypersensitivity for element of PEG-IFN alpha-2a or other IFNs 5. Patient who has previous history of hypersensitivity for biological products such as vaccines 6. Patient with cirrhosis, liver failure, and liver carcinoma 7. Hepatic encephalopathy, an esophageal varix, a patient with abdominal dropsy, or a patient with these previous history 8. A patient with autoimmune diseases (hemolytic anemia, chronic ulcerative colitis, rheumatoid arthritis, etc.), or a patient with these anamneses 9. Patient who has heart disease difficult to control (cardiac infarction, cardiac failure, and arrhythmia, etc.) 10. Patient who exists in serious state of mental disease of serious depression, thought of suicide or suicide plan, etc. or with these history 11. The patient of uncontrollable hypertension 12. A patient with the past of apoplexy (cerebral infarction, cerebral hemorrhage, subarachnoid bleeding, transient ischemic attack) 13. Pregnant woman or woman who has possibility of pregnancy or woman while suckling 14. Additionally, patient judged by doctor that participation in this study is improper 15. The patient who has the resistant to nucleic acid analog, such as Lamivudine and Entecavir
研究者
相似试验
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a for the treatment of chronic hepatitis B.chronic hepatitis BJPRN-UMIN000006649Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine100
招募中
Unknown
Assessment of efficacy and safety of PEG-IFN alpha-2a administration into patients with chronic hepatitis B on nuleoside analogueChronic hepatitis BJPRN-UMIN000015633Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College100
已完成
4 期
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral roadchronic hepatitis CJPRN-UMIN000001170Gunma Liver Study Group220
已完成
不适用
PEG-IFN Alpha (Injection) in Chronic Hepatitis B Patients.CTRI/2017/07/008991Institute of liver and Biliary Sciences118
招募中
2 期
A Phase2 study of the safety and efficacy of pegfilgrastism for the prevention of febrile neutropenia in patients receiving TPF therapy for squamous cell carcinoma of the head and neck.JPRN-jRCTs031220695Saito Yuki18